Pioneering Medicines: Biologic Formulations Technical Operations Co-Op

Pioneering Medicines (PM) is dedicated to conceiving and developing a broad portfolio of life-changing treatments by leveraging and expanding the use of Flagship’s multiple bioplatforms and Flagship’s proprietary innovation process. By harnessing the power of Flagship’s first-in-category platforms, Pioneering Medicines creates and advances novel medicines, partnering with Flagship companies to accelerate the extension of their portfolios into new areas and show that the platform can be applied more broadly, thereby delivering benefits to more patients, sooner. With a highly experienced drug development team and access to the wide ecosystem of Flagship companies, Pioneering Medicines is well positioned to conceive new medicine ideas both internally and in collaboration with strategic partners and advance these assets through to significant value inflection. Pioneering Medicines currently has multiple programs ongoing with plans to have more than 20 programs in 2025-2026. Pioneering Medicines works with external strategic partners including Novo Nordisk, Pfizer, and the Cystic Fibrosis Foundation and continues to engage in discussions on potential partnerships.

Pioneering Medicines was founded by Flagship Pioneering's venture creation engine that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion in aggregate value. Many of the company’s Flagship has founded have addressed humanity’s most urgent challenges: vaccinating billions of people against COVID-19, curing intractable diseases, improving human health, preempting illness, and feeding the world by improving the resiliency and sustainability of agriculture. Flagship has been recognized twice on FORTUNE’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies and has been twice named to Fast Company’s annual list of the World’s Most Innovative Companies. Learn more about Flagship at www.flagshippioneering.com.

Welcome to Flagship Pioneering Co-Op Program for the cohort dreaming big and taking courageous leaps. You'll join fellow peers across our ecosystem of companies and learning firsthand how we build first-in-category companies. You’ll have access to enrichment sessions, a dedicated professional development track, and a mentor that help guide you toward your next step. By the end, you will carry on a meaningful project outcome, a genuine network, and a front-row view of how Flagship pioneer new ventures that change the world.

About the Role

PM is searching for a Co Op to join our Technical Operations Team to help us advance a number of cutting-edgebiologics, aiming to treat chronic diseases. This is an exciting opportunity that will offer valuable experience in the biotech industry. We are seeking an enthusiastic candidate to function under the guidance and expertise of scientists in Pioneering Medicines’ Technical Operations Team. The successful candidate will work in the lab and help develop and evaluate formulations for biologics across multiple therapeutic areas.

• →
  The preparation of biologics formulation vehicles
   
• →
  The creation and screening of multiple biologics and potential nucleic acid payloads
• →
  The development of processes and techniques to improve the overall yield and purity of drug products
• →
  The evaluation of biologics/RNA, and formulations using various cutting edge analytical approaches
• →
  The examination of drug product characteristics and stability for pre-clinical use
• →
  Routine documentation and presentation of data to cross-functional team members

Basic Qualifications:

Preferred Qualifications: